Recent increase in mortality from byaline membrane disease

doi:10.1016/S0022-3476(60)80083-2

The Journal of Pediatrics

Volume 57, Issue 4, October 1960, Pages 553-559

https://doi.org/10.1016/S0022-3476(60)80083-2 Get rights and content

Summary

The “incidence” of fatal hyaline membrane disease in the Johns Hopkins Hospital has been compared for two 5 years periods. During the first, 1944–1948, oxygen was widely used in the premature nursery, beginning 30 to 60 minutes after delivery. The second, 1954–1958, was an era when the concentration of oxygen in the incubators was usually restricted to below 40 per cent. A slight increase in the “incidence” of the disease in the later period makes it evident that low oxygen concentrations after the first 30 minutes were not associated with a decrease in the “incidence” of hyaline membrane disease.

The proportion of autopsies on premature infants showing hyaline membrane disease increased from 21.9 per cent in 1944–1948 to 26.2 per cent in 1954–1958.

References (15)

AveryM.E. et al.
Surface Properties in Relation to Atelectasis and Hyaline Membrane Disease
A. M. A. J. Dis. Child.
(1959)
LiebermanJ.
Clinical Syndrome Associated With Deficient Lung Fibrinolytic Activity: 1. A. New Concept of Hyaline Membrane Disease
New England J. Med.
(1959)
SilvermanW. et al.
“Incidence” of Hyaline Membrane in Premature Infants
Lancet
(1958)
AveryM.E. et al.
“Incidence” of Hyaline Membrane in Premature Infants
Lancet
(1958)
JamesL.S.
Physiology of Respiratory and the Respiratory Distress Syndrome
Pediatrics
(1958)
IngallsT.H.
Epidemiology of Retrolental Fibroplasia in Etiologic Relation to Pulmonary Hyaline Membrane
New England J. Med.
(1954)
BrunsP.D. et al.
High Oxygen and Hyaline-like Membranes
Am. J. Obst. & Gynec.
(1954)

There are more references available in the full text version of this article.

Cited by (128)

Noninvasive monitoring of gas exchange
2022, Goldsmith's Assisted Ventilation of the Neonate: An Evidence-Based Approach to Newborn Respiratory Care, Seventh Edition
Automation of oxygen titration in preterm infants: Current evidence and future challenges
2021, Early Human Development
Citation Excerpt :
We contend that there is a need for: i) rigorously conducted randomised controlled trials of automated oxygen control, ii) a better understanding of the function and comparative performance of contemporary control algorithms, iii) enhancement and individualisation of algorithm performance through adaptation, and iv) application of this technology in low resource settings in which the majority of preterm infants receive care. Oxygen therapy is a cornerstone of management for preterm infants with respiratory insufficiency, and over the years has aimed to overcome the long-recognized consequences of extreme hypoxaemia, including death and neurodevelopmental impairment [1–3]. More recent data from the SpO2 targeting trials assembled by the NeOProM collaborators indicate that even mild hypoxia (SpO2 target range 85–89%) imparts an additional mortality risk, at least in the extremely preterm group [4].
For the preterm infant with respiratory insufficiency requiring supplemental oxygen, tight control of oxygen saturation (SpO₂) is advocated, but difficult to achieve in practice. Automated control of oxygen delivery has emerged as a potential solution, with six control algorithms currently embedded in commercially-available respiratory support devices. To date, most clinical evaluations of these algorithms have been short-lived crossover studies, in which a benefit of automated over manual control of oxygen titration has been uniformly noted, along with a reduction in severe SpO₂ deviations and need for manual FiO₂ adjustments. A single non-randomised study has examined the effect of implementation of automated oxygen control with the CLiO₂ algorithm as standard care for preterm infants; no clear benefits in relation to clinical outcomes were noted, although duration of mechanical ventilation was lessened. The results of randomised controlled trials are awaited. Beyond the gathering of evidence regarding a treatment effect, we contend that there is a need for a better understanding of the function of contemporary control algorithms under a range of clinical conditions, further exploration of techniques of adaptation to individualise algorithm performance, and a concerted effort to apply this technology in low resource settings in which the majority of preterm infants receive care. Attainment of these goals will be paramount in optimisation of oxygen therapy for preterm infants globally.
Targeting Arterial Oxygen Saturation by Closed-Loop Control of Inspired Oxygen in Preterm Infants
2019, Clinics in Perinatology
Citation Excerpt :
Most extreme premature infants require oxygen supplementation to maintain adequate arterial oxygen levels, and the need for supplemental oxygen can extend for several weeks after birth. Although essential for avoiding the deleterious effects of hypoxia,1–3 excessive arterial oxygen levels have been associated with eye, lung, and central nervous system (CNS) damage.4–9 More recently, clinical trials have shown increased mortality with exposure to lower saturation ranges10,11 and detrimental pulmonary and hemodynamic effects associated with insufficient oxygenation.12–16
Optimal Oxygenation in Extremely Preterm Infants
2018, The Newborn Lung: Neonatology Questions and Controversies, Third Edition
Some of the complications associated with extreme immaturity are potentiated by an excess of free radicals. However, hypoxemia may also cause adverse outcomes. Oxygen saturation targeting starting at birth in preterm infants has been based on observational data and expert opinion. Data from the five randomized controlled trials included a total of 4965 extremely preterm infants less than 28 weeks’ gestation. The meta-analysis of these trials shows an increased risk of mortality and necrotizing enterocolitis and a decreased risk of retinopathy of prematurity with targeting oxygen saturation ranges of 85% to 89% compared with targeting of 91% to 95%. There was no difference in blindness or neurodevelopmental outcomes at 18 to 24 months follow-up. Many updated guidelines now recommend targeting oxygen saturation levels as measured by pulse oximetry similar to the range of oxygen saturation found to reduce mortality in these trials (91%–95%).
Neonatal Respiratory Therapy
2018, Avery's Diseases of the Newborn: Tenth Edition
Close monitoring of blood gases and respiratory status is key in assessing the clinical course and the adequacy of the respiratory support in neonates with respiratory failure. This is important to assure the best possible outcome and in particular, to avoid some of the frequent complications associated with respiratory support. This is most critical in neonates born at lower gestational ages where the rate of complications is higher. In this chapter we discuss the most common methods used for neonatal monitoring and for invasive and noninvasive respiratory support. We also describe some of the newer strategies to reduce complications and improve the outcomes of neonates with respiratory failure.
Neonatal Respiratory Therapy
2017, Avery's Diseases of the Newborn, Tenth Edition
Close monitoring of blood gases and respiratory status is key in assessing the clinical course and the adequacy of the respiratory support in neonates with respiratory failure. This is important to assure the best possible outcome and in particular, to avoid some of the frequent complications associated with respiratory support. This is most critical in neonates born at lower gestational ages where the rate of complications is higher. In this chapter we discuss the most common methods used for neonatal monitoring and for invasive and noninvasive respiratory support. We also describe some of the newer strategies to reduce complications and improve the outcomes of neonates with respiratory failure.

View all citing articles on Scopus

^*: This study was supported in part by a special traineeship BT 259 C2 from the National Institute of Neurological Diseases and Blindness, Public Health Service.

^*: Address, Department of Pediatrics, The Johns Hopkins Hospital, Baltimore 5, Md.

View full text

Recent increase in mortality from byaline membrane disease*

Summary

Surface Properties in Relation to Atelectasis and Hyaline Membrane Disease

A. M. A. J. Dis. Child.

Clinical Syndrome Associated With Deficient Lung Fibrinolytic Activity: 1. A. New Concept of Hyaline Membrane Disease

New England J. Med.

“Incidence” of Hyaline Membrane in Premature Infants

Lancet

“Incidence” of Hyaline Membrane in Premature Infants

Lancet

Physiology of Respiratory and the Respiratory Distress Syndrome

Pediatrics

Epidemiology of Retrolental Fibroplasia in Etiologic Relation to Pulmonary Hyaline Membrane

New England J. Med.

High Oxygen and Hyaline-like Membranes

Am. J. Obst. & Gynec.